Compare SSSS & ENLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SSSS | ENLV |
|---|---|---|
| Founded | 2010 | 2005 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Finance: Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.4M | 196.2M |
| IPO Year | N/A | 2014 |
| Metric | SSSS | ENLV |
|---|---|---|
| Price | $13.27 | $0.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 2 |
| Target Price | $15.67 | ★ $20.00 |
| AVG Volume (30 Days) | 410.2K | ★ 539.3K |
| Earning Date | 05-12-2026 | 05-29-2026 |
| Dividend Yield | ★ 7.56% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $42.86 | N/A |
| P/E Ratio | $3.61 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.50 | $0.66 |
| 52 Week High | $13.66 | $2.10 |
| Indicator | SSSS | ENLV |
|---|---|---|
| Relative Strength Index (RSI) | 65.45 | 41.42 |
| Support Level | $8.63 | $0.79 |
| Resistance Level | N/A | $1.23 |
| Average True Range (ATR) | 0.53 | 0.07 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 80.00 | 46.46 |
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.
Enlivex Ltd is a clinical stage macrophage reprogramming immunotherapy company currently focused on the late-stage clinical development of Allocetra, a novel therapy designed to treat the joint disease osteoarthritis. Additionally, it has developed a treasury using the RAIN protocol, which currently serves as the primary treasury reserve asset of the company.